menu
Your Cart

ITA8138

ITA8138-1
ITA8138-2
ITA8138-1
ITA8138-2
ITA8138
  • Catalog: ITA8138
  • Gene/Protein: LEFTY2
  • Product Description: Immunotag™ LEFTY2 Antibody
385.0000
Price in reward points: 385

Available Options

Immunotag™ LEFTY2 Antibody
Antibody Specification
Datasheet

Target Protein LEFTY2
Clonality Polyclonal
Storage/Stability -20°C/1 year
Application WB,IHC,ELISA
Recommended Dilution WB 1:1000-3000 IHC 1:200
Concentration 1 mg/ml
Reactive Species Human,Mouse,Rat
Host Species Rabbit
Immunogen A synthesized peptide derived from human LEFTY2
Specificity LEFTY2 Antibody detects endogenous levels of total LEFTY2
Purification The antiserum was purified by peptide affinity chromatography.
Form Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt
Gene Name LEFTY2
Accession No. O00292
Alternate Names EBAF; Endometrial bleeding associated factor (left right determination factor A transforming growth factor beta superfamily); Endometrial bleeding associated factor; Endometrial bleeding-associated factor; Left right determination factor 2; Left right determination factor A; Left-right determination factor 2; Left-right determination factor A; LEFTA; LEFTY 2; LEFTY2; LEFTYA; LFTY2 transforming growth factor, beta -4; LFTY2, mouse, homolog of; LFTY2_HUMAN; MGC46222; Protein lefty 2; Protein lefty A; Protein lefty-2; Protein lefty-A; Protein lefty2; PSEC0024; TGF beta 4; TGF-beta-4; TGFB4; Transforming growth factor beta 4; Transforming growth factor beta-4;
Description Required for left-right (L-R) asymmetry determination of organ systems in mammals. May play a role in endometrial bleeding.
Cell Pathway/ Category Primary Polyclonal Antibody
Protein MW 41 kDa
Usage For Research Use Only! Not for diagnostic or therapeutic procedures.
Material Safety Data Sheet
English_US
Danish
Dutch
English_UK
French
German
Spanish
Norwegian
Portuguese
Finnish
Swedish
Polish

Write a review

Note: HTML is not translated!
Bad Good
Captcha

CONNECT WITH US